Peter Olagunju is Chief Operating Officer of TCR2 THERAPEUTICS INC.. Currently has a direct ownership of 0 shares of TCRR, which is worth approximately $0. The most recent transaction as insider was on Jun 01, 2023, when has been sold 24,092 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Peter Olagunju Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 01 2023
SELL
Sale (or disposition) back to the issuer
-
24,092 Reduced 100.0%
0 Common Stock
Dec 13 2022
SELL
Open market or private sale
$1,758 $1.06 p/Share
1,659 Reduced 6.44%
24,092 Common Stock
Dec 12 2022
SELL
Open market or private sale
$1,771 $1.1 p/Share
1,610 Reduced 5.88%
25,751 Common Stock
Dec 09 2022
SELL
Open market or private sale
$1,763 $1.13 p/Share
1,561 Reduced 5.4%
27,361 Common Stock
Dec 08 2022
SELL
Open market or private sale
$1,762 $1.25 p/Share
1,410 Reduced 4.65%
28,922 Common Stock
Dec 07 2022
SELL
Open market or private sale
$1,763 $1.28 p/Share
1,378 Reduced 4.35%
30,332 Common Stock
Dec 06 2022
SELL
Open market or private sale
$1,764 $1.33 p/Share
1,327 Reduced 4.02%
31,710 Common Stock
Dec 05 2022
SELL
Open market or private sale
$1,768 $1.37 p/Share
1,291 Reduced 3.76%
33,037 Common Stock
Dec 02 2022
SELL
Open market or private sale
$1,769 $1.39 p/Share
1,273 Reduced 3.58%
34,328 Common Stock
Dec 01 2022
BUY
Exercise of conversion of derivative security
-
33,409 Added 48.41%
35,601 Common Stock
PO

Peter Olagunju

Chief Operating Officer
Boston, MA

Track Institutional and Insider Activities on TCRR

Follow TCR2 THERAPEUTICS INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TCRR shares.

Notify only if

Insider Trading

Get notified when an Tcr2 Therapeutics Inc. insider buys or sells TCRR shares.

Notify only if

News

Receive news related to TCR2 THERAPEUTICS INC.

Track Activities on TCRR